NEOG
NEOG
NASDAQ · Health Care

Neogen Corp

$9.53
+0.13 (+1.38%)
As of May 9, 1:28 AM ET ·
Financial Highlights (FY 2026)
Revenue
848.42M
Net Income
-1,035,586,420
Gross Margin
47.1%
Profit Margin
-122.1%
Rev Growth
+19.3%
D/E Ratio
0.43
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 47.1% 47.1% 58.3% 58.3%
Operating Margin -118.6% -106.7% 15.7% 16.2%
Profit Margin -122.1% -116.0% 11.6% 12.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 848.42M 711.28M 855.36M 756.81M
Gross Profit 399.60M 335.01M 498.56M 441.12M
Operating Income -1,006,136,700 -759,157,469 134.03M 122.48M
Net Income -1,035,586,420 -781,378,083 98.99M 96.55M
Gross Margin 47.1% 47.1% 58.3% 58.3%
Operating Margin -118.6% -106.7% 15.7% 16.2%
Profit Margin -122.1% -116.0% 11.6% 12.8%
Rev Growth +19.3% +19.3% -2.9% +12.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 295.52M 295.52M 498.80M 403.07M
Total Equity 684.55M 684.55M 1.03B 1.23B
D/E Ratio 0.43 0.43 0.49 0.33
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -892,740,531 -711,019,034 210.94M 195.24M
Free Cash Flow 98.90M 73.84M